In experimental models of breast cancer, inhibitors of CSF1R signaling have been shown to enhance the effectiveness of chemotherapy or radiotherapy by suppressing tumor growth and the spread of cancer to other parts of the body [15,87]. Here, CSF1R is linked to breast carcinoma.